Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Elashoff

Showing results (1-10 of 375) with videos related to

Pageof 38
Sort By:
Stroke|February 21, 2009
Green and black tea consumption and risk of stroke: a meta-analysisLenore Arab, Weiqing Liu, David Elashoff
Pharmacology, Biochemistry, and Behavior|January 31, 2004
Precipitated opioid withdrawal across acute physical dependence induction methodsPeggy Compton, Karen Miotto, David Elashoff
The Journal of Pain|November 26, 2003
Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary studyPeggy Compton, Peter Athanasos, David Elashoff
Nutrients|January 30, 2019
Lower Depression Scores among Walnut Consumers in NHANESLenore Arab, Rong Guo, David Elashoff
Artificial Intelligence in Medicine|June 6, 2019
Sparse support vector machines with L<sub>0</sub> approximation for ultra-high dimensional omics dataZhenqiu Liu, David Elashoff, Steven Piantadosi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2004
Assessing prognosis in non-small-cell lung cancer: avenues to a more complete picture?Steven M Dubinett, David Elashoff, Matthew Meyerson
Annals of Surgical Oncology|September 30, 2006
The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysisDouglas Iddings, Aziz Ahmad, David Elashoff, et al.
BMJ Open|September 23, 2019
Association between physician characteristics and payments from industry in 2015-2017: observational studyKosuke Inoue, Daniel M Blumenthal, David Elashoff, et al.
Neurobiology of Aging|March 1, 2016
Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trialsJoshua D Grill, Yan Zhou, David Elashoff, et al.
Alzheimer Disease and Associated Disorders|January 1, 2015
Frequency and impact of informant replacement in Alzheimer disease researchJoshua D Grill, Yan Zhou, Jason Karlawish, et al.
Pageof 38

Showing results (1-10 of 375) with videos related to

Sort By:
Pageof 38
Stroke|February 21, 2009
Green and black tea consumption and risk of stroke: a meta-analysisLenore Arab, Weiqing Liu, David Elashoff
Pharmacology, Biochemistry, and Behavior|January 31, 2004
Precipitated opioid withdrawal across acute physical dependence induction methodsPeggy Compton, Karen Miotto, David Elashoff
The Journal of Pain|November 26, 2003
Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary studyPeggy Compton, Peter Athanasos, David Elashoff
Nutrients|January 30, 2019
Lower Depression Scores among Walnut Consumers in NHANESLenore Arab, Rong Guo, David Elashoff
Artificial Intelligence in Medicine|June 6, 2019
Sparse support vector machines with L<sub>0</sub> approximation for ultra-high dimensional omics dataZhenqiu Liu, David Elashoff, Steven Piantadosi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2004
Assessing prognosis in non-small-cell lung cancer: avenues to a more complete picture?Steven M Dubinett, David Elashoff, Matthew Meyerson
Annals of Surgical Oncology|September 30, 2006
The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysisDouglas Iddings, Aziz Ahmad, David Elashoff, et al.
BMJ Open|September 23, 2019
Association between physician characteristics and payments from industry in 2015-2017: observational studyKosuke Inoue, Daniel M Blumenthal, David Elashoff, et al.
Neurobiology of Aging|March 1, 2016
Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trialsJoshua D Grill, Yan Zhou, David Elashoff, et al.
Alzheimer Disease and Associated Disorders|January 1, 2015
Frequency and impact of informant replacement in Alzheimer disease researchJoshua D Grill, Yan Zhou, Jason Karlawish, et al.
Pageof 38